If soy isoflavones are to be effective in preventing or treating a range of diseases, they must be bioavailable, and thus understanding factors which may alter their bioavailability needs to be elucidated. However to date there is little information on whether the pharmacokinetic profile following ingestion of a defined dose is influenced by the food matrix in which the isoflavone is given or by the processing method used. Three different foods (cookie, chocolate bar and juice) were prepared and their contents on isoflavones was determined. We compared the urinary and serum concentrations of daidzein, genistein and equol following the consumption of three different foods each of which contained 50 mg of isoflavones.
INTRODUCTION
Although dietary isoflavones, which are present in soybeans, have gained significant attention in relation to their risk:benefit profile for human health [1] , there are still no clear guidelines on safe and efficacious doses. What is critical to the biological efficacy and safety of these compounds is a thorough understanding of their bioavailability from different soya foods.
Following ingestion, the isoflavone glucosides are hydrolysed by intestinal -glucosidases to produce aglycones in the small intestine [2, 3] which are then either absorbed intact or further metabolised by intestinal microflora in the large intestine into other metabolites like equol and O-desmethylangolensin (ODMA) [4, 5] . In soyabeans, isoflavones are present in different chemical forms; aglycones, -glucosides, malonyland acetyl-glucosides. However, although in soya foods the predominant form is the glucosides, food processing techniques can alter the ratio of glucosides present and fermentation processes can result in increases in the levels of aglycones present in commercially available soya products. The major isoflavones in soyabeans are daidzin and genisitin as glycosides and their corresponding aglycone forms, daidzein and genistein [6] .
Several recent studies have investigated the potential relationship between isoflavones in the glucoside and aglycone form from both pure compounds and soy foods to assess their effects on absorption, distribution, metabolism and excretion in animal and human studies [7, 8, 9] . However, some data reported that isoflavone aglycones (present in fermented soya products) were absorbed more efficiently than isoflavone glycosides [10] while other data suggests that the resulting bioavailability of daidzein and gensitein was 4 greater when the soy isoflavones were ingested as glucosides rather than aglycones [11] and in one study no different in the apparent bioavailability following consumption of aglycone or glucoside tablets [12] . The distinct disparity in these results may be explained by factors such as age, gender or the type of soy food or isoflavone preparation
fed. However what is ultimately important is to understand if the levels attained in urine and serum are similar following consumption of a known dose of isoflavones but present in different food matrices. Therefore in the current study, we have examined the effect of food matrix on the apparent bioavailability of isoflavones from soy foods. A group of postmenopausal women were studied on three separate occasions and were randomly assigned to consume three different food matrices which each containing 50 mg of soy isoflavones.
METHODS AND MATERIAL

Chemicals
All chemicals used were of analytical grade. Special reagents were daidzein, daidzin, 6"-O-acetyldaidzin, genistein, genistin, 6"-O-acetylgenistin, glycitein, glycitin and 6"-Oacetylglycitin (LC laboratories, Woburn, USA), pancreatine from porcine pancreas, bile extract from pork, pepsine from porcine stomach and trypsine from bovine pancreas (Sigma) .
Sample preparation
455 mg of an isoflavone rich extract with a total isoflavone content of 11 wt % (SoyLife Extra®, Acatris B.V., Giessen, The Netherlands) was incorporated into three different food products; fruit juice (Döhler), chocolate bars (VSI) and cookies (A&F). The criteria 5 used for test food selection were: liquid-solid matrix effect, thechnological suitability as isoflavones carriers and consumers preferences within the group of study. Apple juice, orange juice or mandarin juice served as starting beverage compound together with sugar, citric cid, aroma and less than 0.1 % CO 2 . After addition of SoyLife Extra® the beverage was diluted with water to ready-to-drink strength produced the fruit juice. The resulting beverage was filled in bottles and pasteurized (10 min 80C). Chocolate bars were made by mixing SoyLife Extra® and the syrup components at maximum 55 °C. It was casted in a flat mold, cooled, sliced into pieces and coated with chocolate. The cookies were made by mixing SoyLife Extra® with margarine, self-rising flour, wholemeal flour, sugar and spices and the baked for 15 min at 150C. Juice, cookies and bars contained respectively (g per serving): protein, 0, 2 and 18; fat, 0, 8, and 6; carbohydrates, 40, 20 and 22.
Placebo foods were prepared in the same way as the isoflavone enriched foods.
Isoflavone content and composition of the products
A representative sample (2 mL or 2 g) was taken from all of these three products (n=3 samples of each food) and the isoflavone content was determined by extraction and 
In vitro digestion of the isoflavone enhanced foods
For the digestion 2 g food were suspended in 20 mL MilliQ water. 8 mL stomach fluid (pH 2.5) was added and the mixture kept at 37°C in a shaking water-bath for 1 h.
Immediately after, 10mL intestine juice, 0.4 ml trypsin solution and 0.4 ml buffer solution were added and the pH was adjusted to 6.5 using 1 M NaHCO 3 . The mixture was kept at 37 °C in a shaking water bath for another 2h. After the digestion was finished a 1:1 dilution was made by adding 100% acetonitrile and the resulting solution injected in the HPLC for analysis.
The stomach fluid contained 0.07 mg pepsin per ml stomach electrolyte. Stomach electrolyte solution contained 53 mM NaCl, 1 mM CaCl 2 , 14.8 mM KCl and 5.7 mM Na 2 CO 3 and was adjusted to pH 2.5 using 2M HCl. The intestine juice was made in two consecutive steps. First 25 g intestine electrolyte was mixed with 7 g pancreatine and 73
gr MilliQ water. This solution was mixed for 10 minutes and subsequently centrifuged for 20 minutes at 4 °C and 9800 g. In the second step0.475 g bile was added to 25 mL 7 supernatant. The intestine electrolyte contained 21 mM NaCl, 2 mM KCl and 0.5 mM CaCl 2 .
Recruitment and screening of subjects
Subjects
The single oral bolus dose food studies were conducted on postmenopausal women recruited from the staff and adult population from within and around the University of Reading, United Kingdom (UK) and The Royal Veterinary and Agricultural University, Frederiksberg, Denmark (DK). 12 postmenopausal women were enrolled to participate in these studies, 6 in DK and 6 in UK All individuals were healthy, had normal liver and kidney function accessed by serum aspartate amine transpherase (ASAT), alanine amino transpherase (ALAT) and creatinine, reported no use of medications (including antibiotic use within the preceding 3 months), no HRT users, did not consume soy-rich foods on a regular basis and reported no menstrual bleeds for at least two years prior to the commencement of the study. The study design and protocol were approved by the
University of Reading and the Municipal Ethical Committee of Copenhagen and
Frederiksber and informed consent was obtained from each subject following a detailed explanation of the study procedure.
Design of study
Subjects were asked to refrain from eating foods containing soy products for at least one month prior to the start of the study and for the duration of the study. Following an overnight fast, each individual arrived at the Reading and Frederiksberg research centres (n= 6 per study site) and following a standardised breakfast, were randomly assigned 8 (using a multiple cross-over design) to receive one of the three isoflavone-rich foods on three separate occasions. Each oral dosing was separated by a minimum of one week. All subjects received the three different food items; cookies, chocolate bar, and juice (with an average content of 53.0  3.9 mg isoflavones in which aglycones represented 2.0% and the ratio ratio of daidzein and its glucosides over genistein and its glucosides was 5.0  0.1) together with the standardised breakfast at each visit.
A baseline 10 ml blood sample was collected prior to soy food ingestion. After the ingestion of the isoflavone-rich food over a period of 20 minutes (under supervision to ensure complete intake), further blood samples were obtained at 4, 6, 8, 12, 24, 48hrs after dosing. Blood was obtained by venepuncture .2x 5 ml Blood samples were centrifuged at 1600 g for 10 min at 4C and aliquots of serum (2x0.5 ml) stored at -20C until further analysis.
24 hr urine collections were made over the 48 hour study period. 4 x 25 ml aliquots from each 24 hr collection were stored at -20ºC until further analysis
Serum and urinary isoflavone analysis
Daidzein, Genistein and Equol concentrations were determined in serum and urine by Time-Resolved Fluoroimmunoassay (TR-FIA). Samples were analysed for daidzein using a previously published TR-FIA [13] . Based on this established format, similar TR-FIA assays for genistein and equol, using monoclonal antibodies prepared by the Unilever Colworth monoclonal group, were developed. Commercial assays were not available at the time. diethyl ether. The water phase was frozen in a dry ice -ethanol mixture and the ether phase transferred into a glass tube. After thawing the water phase was re-extracted with 10 ether and the ether phases were combined and evaporated to dryness in a +450C water bath. 200mL DELFIA assay buffer was then added to each tube and they were vortexed to reconstitute the extracted sample prior to DELFIA analysis.
The genistein assay on extracted serum used an alternative in-house antibody 6606.1 with a more appropriate sensitivity and specificity profile for blood analysis (Genistein: inhouse clone 6606.1, 200 ng/ml). Otherwise assay conditions were as described for urine analysis.
Statistical analyses and Pharmacokinetic parameters
Statistical analysis was performed by using the SPSS software package for Windows was defined as the time in hours at which c max was reached. The elimination half-life for genistein, daidzein and equol was computed by using the following formula: t 1/2 = -ln(2)/, where  is the slope of the linear regression of the ln of serum genistein, daidzein and equol concentrations 8, 12, 24 and 48 h after isoflavones enriched foods.
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RESULTS
Isoflavone contents in the foods
In Figure 1 we show a chromatogram corresponding to one of the analysed foods as an example of the profile of isoflavones obtained. Daidzein, daidzin, 6"-O-acetyldaidzin, genistein, genistin, 6"-O-acetylgenistin, glycitein, glycitin and 6"-O-acetylglycitin where all present in all the analysed samples.
In the isoflavone enriched food materials less than 4% total aglycones were present (including glycitein) ( Table 1) . About 65 to75 % of the total isoflavone content was present as glucoside, the remaining part as acetylglucoside. The D/G ratio was 5.0 ± 0.2 (95 % CI) for the prepared foods. Isoflavones concentrations were not significantly different in the three tested products.
In vitro digestion of the isoflavone enhanced foods
After in vitro digestion the cookies differed significantly from the other two product types in % recovery of total isoflavones (see Table 2 ). No significant difference in % recovery was observed between bars and juice. Significant differences where also observed in the case of the cookies between the ratio in the original food and after in vitro digestion. Proportionally, in this model system, a higher amount of genistein was absorbed compared with daidzein.
In vivo absorption of isoflavones from the isoflavone enhanced foods
Twelve healthy volunteers (six in UK and six in DK) were recruited and completed the three phases of the study. Pre-study screening data are given in Table 3 .
Volunteers were fed a food containing the 50mg of isoflavones, as either, a cookie, chocolate bar or juice. Based on the 50 mg isoflavones, the subjects each consumed: 6.7 12 mg genistein and 33.8 mg daidzein, both predominantly in the glycoside form (aglycones< 4.4% in every case)
Serum levels
Serum genistein was 0.9 ± 5.39 ng/ml, 0.9± 4.62 ng/ml and 2.0± 11.89 ng/ml prior to ingestion of cookies, bars and juice respectively. Prior to isoflavone administration, serum daidzein was 0.1 ± 1.55 ng/ml, 0.2 ± 1.12 ng/ml and 0.1 ± 1.37 ng/ml, while baseline serum equol concentrations were 0.6 ± 0.57 ng/ml, 0.5± 0.26 ng/ml and 0.4± 0.23 ng/ml respectively. Changes in serum total genistein, daidzein and equol concentrations during the 48 h after ingestion of the meal varied substantially between the individuals.
After consumption of the test foods containing isoflavones, serum genistein concentrations increased to 160.9 ± 74.88 ng/ml, 157.5 ± 61.74 ng/ml and 129.1 ± 86.22 ng/ml in the cookies, bars and juice respectively (Figure 2a) . Peak genistein concentrations were reached at time 8 h for cookies and bars and at time 6h following consumption of the juice.
Serum daidzein concentrations increased to a maximum concentration of 116.8 ± 28.67 ng/ml, 127.2 ± 20.36 ng/ml and 112.1 ± 30.37 ng/ml following ingestion of the cookies, bars and juice respectively (Figure 2b) . Peak daidzein concentration was attained at time 8 h for all the tested foods.
Negligible increases in serum equol concentrations were observed in this study group; 1.2 ± 0.41 ng/ml, 1.1 ± 0.40 ng/ml and 1.2 ± 0.52 ng/ml following ingestion of the cookies, bars and juice respectively (Figure 2c) . However, peak equol concentrations were reached at 12 h for all the tested foods. 13 Forty-eight hours after ingestion of the isoflavone-enriched foods, mean serum genistein concentrations had dropped to 8.5 ± 16.49 ng/ml, 3.8 ± 6.51 ng/ml and 2.5 ± 6.93 ng/ml in the three study phases. Serum daidzein was 0.7 ± 2.14 ng/ml, 0.4 ± 2.75 ng/ml and 0.8 ± 1.84 ng/ml 48 h after ingestion of cookies, bars and juice respectively. AUC, c max , t max and t 1/2 values were calculated for serum total genistein, daidzein and equol after ingestion of the isoflavone enriched cookies, bars and juice ( Table 4) . 
Urinary levels
50% of the ingested genistein was eliminated in urine in the first 24 hours and a further 11% on the second study day after consumption of the juice. In the case of cookies and bars 56% and 55% were eliminated after 24 hours respectively and a further 12% and 11% on the second day (Figure 3a) .
For daidzein 31%, 30% and 29% of the dose was excreted in urine in the first 24 hours after ingestion of cookies, bars and juice respectively and a further 4% on the second day (Figure 3b) .
Approximately half of the excreted equol was determined in urine in the first 24 hours and the rest on the second day (Figure 3c) .
DISCUSSION
Isoflavones may be important in the prevention and or treatment of a range of chronic diseases and data from in vitro model systems, animal studies and intervention trials in 14 humans attest to the biological activity of these compounds and their potential importance to human health [1] . Although rates of hormone dependent diseases are lower in populations who consume relatively high intakes of soy isoflavones, if soy isoflavones are to be effective in preventing or treating a range of diseases, they must be bioavailable, and thus understanding factors which may alter their bioavailability needs to be elucidated.
It is well established that soy isoflavones are readily absorbed from the gastrointestinal tract and reach peak concentrations within a few hours of ingestion [11] . A small number of studies have evaluated the levels of soy isoflavones attained in serum or urine but many have either focused on a single food [7, 8, 9] or studied specific purified aglycones or glycosides [10, 11] . There is little information, however, as to whether the appearance and disappearance of isoflavones in urine and serum is influenced by the food matrix in which the isoflavones are contained. The aim of this study was to determine the effect of food matrix on the levels of isoflavones attained in serum and urine in a group of healthy postmenopausal women given an oral dose of three different foods containing a defined level of isoflavones (50 mg) on three separate occasions.
The studies were preformed according to a classic single oral bolus dose pharmacokinetic design, using a level of intake which was reflective of habitual intake in Asia and are complementary to previously published studies which used stable isotopes of the pure compounds or soy foods [9, 14] . These data clearly demonstrate that humans absorb isoflavones from a range of different food matrices.
In previous studies, several investigators have use a liquid matrix, like soymilk [15] , specific soy beverages [16] or soy-rich preparations suspended in liquids [7, 8] . In the 15 present study, t max following juice consumption was 7.8  1.8 h and 7.0  0.1 h for daidzein and genistein respectively. This is in agreement with other studies employing liquid food preparations where the mean t max occurs between 6 and 9 h for both daidzein and genistein [7, 8, 16, 17] .
When we compared the isoflavone concentrations after the technological processing of the different test foods we only found differences in aglycone levels. For the cookies, the level of aglycones, of both genistein and daidzein, were slightly higher (3.0  1.4) than those in the juice or chocolate bars (1.5  2.5 and 1.5  0.7 respectively). However these differences did not seem to have any effect on the Cmax obtained after the ingestion of the three test foods.
With regards to the in vitro bioavalability assay, the results showed a very low recovery of isoflavones from the cookies. This result could be due to the high complexity of the matrix of the cookies, with a high content of sugars and proteins, which may make the extraction of isoflavones more difficult. However these results were not reflected in the human study and add weight to the difficulties in extrapolating results from in vitro experimentation to help understand the human absorption of bioactive compounds from food.
In agreement with previous studies, wide inter-individual variability in the urinary recovery of daidzein and genistein was observed [18, 19] . In the current study (n=12), recovery of total daidzein and genistein was 38.8% ( 5.3) of total isoflavones ingested with daidzein and genistein recoveries ranging from 32-35% and 61-70%. Following soy food consumption, it is well established that urinary daidzein concentrations are consistently higher than urinary genistein levels [7, 8, 9, 15] . Given the profile of the soy 16 isoflavone extract (41.8 mg daidzein, 8.2 mg genistein) added to our three food matrices, it was thus not surprising that daidzein levels in urine were consistently higher than urinary genistein levels. However in the present study the percentage of genistein eliminated in urine was higher than that of daidzein. This is possibly due to the fact that in our study the relative proportions of daidzein:genistein in the food were 5:1 while in most of the previous studies the proportion is approximately 1:1.
The excretion profiles of daidzein and genistein over the 48 hrs following ingestion of the soy foods are similar to that which we previously observed [9] with the majority appearing in the urine within the first 24 h following the ingestion of the soy food. This rapid appearance of these compounds in urine can be explained by the short serum halflife and fast serum clearance rates of both daidzein and genistein ( Table 4) . Other investigations of the urinary excretion patterns of these compounds following acute ingestion have also reported low excretion rates 24 h post ingestion [7, 8, 9] .
The current study aimed to evaluate the potential impact that food matrix may have on urinary isoflavone excretion following the consumption of a single portion of three foods containing a known dose of soy isoflavones in the same group of subjects. There was a lower total urinary recovery of genistein following ingestion of juice (61%) than that of the other two foods (66% and 70% for bars and cookies respectively). Daidzein recovery remained similar across the three foods ingested with total urinary output 32-35% of ingested intake. These data suggest that the levels of isoflavones attained, particularly levels of genistein, may be altered depending on the food matrix consumed, but the current data did not reach statistical significance. It should be noted that for the given variance in this study for a study power of 80% a minimum of 48 volunters would be 17 necessary in order to get significancy for a 13% difference in isoflavone excretion at a P<0.05.
The metabolites of daidzein and genistein, formed in the intestine may account for some of the rest of the urinary isoflavones levels and various other metabolites have been identified in biological fluids [20, 21, 22, 23] . In this study we focused on the metabolite of daidzein, equol, as a marker of intestinal metabolism. Equol has been the focus of much interest because it is more oestrogenic and a more potent antioxidant than daidzein [24, 25, 26] suggesting that this isoflavone metabolite may hold the key to understanding the mechanism of action and effectiveness of soya in clinical studies examining the potential health benefits of soya isoflavones. It is well established that only 30% of any given population group studied can produce equol [19, 27, 28, 29] and an inability to produce equol may be related to an absence of appropriate enzymes in the intestinal microflora or absence of bacterial species capable of producing equol [20, 30] . Its formation is exclusively related to intestinal microflora as germ free rats do not excrete equol and the absence of equol from infant blood samples following soy infant formula ingestion add weight to the need for an active microflora for its formation [31] . Our studies in healthy adults using C13 daidzein and C13 gensitein show conclusively that equol is formed from daidzein and not genistein [9] . The question of whether we can enhance intestinal conversion of daidzein to equol is one of great interest [17, 20] and dietary carbohydrate has been indicated as a factor that may determine equol production [1, 19, 20, 29] . Surprisingly in the current study none of the subjects were equol producers. 18 This study examined the potential effect of food matrix on the levels of isoflavones attained in urine and serum. The levels of the isoflavone precursor, daidzein did not appear to be altered by food matrix and in this study none of the volunteers appeared capable of converting this precursor to its intestinal metabolite, equol. Peak genistein concentrations were attained in serum earlier following consumption of liquid matrix than a solid matrix however these differences were not statisticaly significatives. Further studies are required to determine the relative importance of food matrix to ensure safe and efficacious doses of these compounds can be delivered for potential health benefits.
The pharmacokinetic data gathered from this study relate well to the limited information available from previous work. More specifically, C max , t max , t 1/2 and AUC (0-t) were all within the range of values obtained from other studies using similar quantities of dietary isoflavones [7, 8, 9, 11, 15] . Accurate measurements of bioavailability would ideally compare the AUC after both oral and intravenous administration. However in any study examining bioavailability, the accuracy is dependent on taking sufficient blood samples during the elimination phase and continuing with sampling ideally to at least five half lives beyond the time that steady state levels are reached in blood. However only a few studies on bioavailability have taken this into consideration [7, 8, 11, 31, 32] while several studies have only used a couple of time points to compute the pharmacokinetic [10, 33] . These inconsistencies in study design and sampling may well account for any discrepancies in the available literature. 
